Flourish Research - Miami, LLC

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Type 2 diabetes2 trials
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Obstructive sleep apnoea1 trial
• Osteoarthritis1 trial
• Peripheral artery disease1 trial
• Stroke1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Eli Lilly and Company5 trials

Running trials

• Not yet recruiting

  A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

  NCT07881432· Phase 3· Eli Lilly and Company· Source

  Contact: Mark Rosenthal (principal investigator)

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  NCT07369011· Phase 3· Eli Lilly and Company· Source

  Contact: Mark Rosenthal (principal investigator)

• Active, not recruiting

  A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

  NCT07035093· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Recruiting

  A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

  NCT05986292· Phase 2· Eli Lilly and Company· Source

  Contact: Mark Kutner (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Obstructive sleep apnoea1 recruiting
• Osteoarthritis1 recruiting
• Type 2 diabetes1 recruiting